Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

IMUX

Immunic, Inc.

Healthcare · USD

Set alert

Price alert · IMUX

All alert types
7.51 USD -0.29 -3.66%
As of Oct 30, 2026 Extended hours 7.62 +1.46%
Bid
7.48 × 2
Ask
7.56 × 1
7.37 Day range 7.78
5.10 52-week range 16.90
YTD
+40.64%
1 year
-4.21%
Open
7.70
Prev close
7.80
Mkt cap
102.47M
Vol
244.43K
Avg vol
335.47K
EPS
-3.83
P/E
0.00
Div yield
0.00%
More statistics
Low
7.37
High
7.78
Forward P/E
-1.67
Beta
1.88
Short ratio
4.69
Inst. own
64.85%
Dividend
0.00
Ex-div date
50-d avg
1.24
200-d avg
1.32
1y target
12.79

5D chart

Chart tools
Interval
1m5m15m30m
IMUX five-day price chart6.997.307.617.918.22Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

-5.35 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 2

Valuation

P/E -0.9×
FY 2016: -3.3×FY 2017: -4.5×FY 2018: -0.5×FY 2019: -2.1×FY 2020: -5.4×FY 2021: -2.4×FY 2022: -0.4×FY 2023: -0.7×FY 2024: -1.0×FY 2025: -0.9×
FY 2016 5y median -0.9× FY 2025
P/S 0.0×
FY 2016: 21620×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
P/B -12.5×
FY 2016: 2.3×FY 2017: 4.7×FY 2018: 0.5×FY 2019: 1.3×FY 2020: 1.5×FY 2021: 1.8×FY 2022: 0.4×FY 2023: 2.3×FY 2024: 5.4×FY 2025: -12.5×
FY 2016 5y median 1.8× FY 2025
P/FCF -1.0×
FY 2016: -3.8×FY 2017: -5.8×FY 2018: -0.1×FY 2019: -2.6×FY 2020: -5.2×FY 2021: -2.7×FY 2022: -0.7×FY 2023: -0.9×FY 2024: -1.2×FY 2025: -1.0×
FY 2016 5y median -1.0× FY 2025
EV/EBITDA -0.7×
FY 2016: -2.0×FY 2017: -3.5×FY 2018: -2.1×FY 2019: -1.2×FY 2020: -2.3×FY 2021: -1.5×FY 2022: 0.7×FY 2023: -0.2×FY 2024: -0.7×FY 2025: -0.7×
FY 2016 5y median -0.7× FY 2025
EV/Sales 0.0×
FY 2016: 12121×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025
FCF Yield -103.4%
FY 2016: -26.6%FY 2017: -17.3%FY 2018: -694.5%FY 2019: -38.2%FY 2020: -19.3%FY 2021: -36.8%FY 2022: -146.5%FY 2023: -107.0%FY 2024: -84.9%FY 2025: -103.4%
FY 2016 5y median -103.4% FY 2025

Profitability

Gross Margin 0.0%
FY 2016: -28529.7%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2016: -653447.6%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2016: -648744.6%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
ROE 1456.2%
FY 2016: -70.1%FY 2017: -104.1%FY 2018: -333.7%FY 2019: -59.7%FY 2020: -27.7%FY 2021: -73.1%FY 2022: -105.9%FY 2023: -323.6%FY 2024: -545.4%FY 2025: 1456.2%
FY 2016 5y median -105.9% FY 2025
ROIC 1693.4%
FY 2016: -70.5%FY 2017: -105.1%FY 2018: -337.1%FY 2019: -62.9%FY 2020: -30.7%FY 2021: -71.6%FY 2022: -103.7%FY 2023: -327.8%FY 2024: -504.6%FY 2025: 1693.4%
FY 2016 5y median -103.7% FY 2025
ROA -404.0%
FY 2016: -64.0%FY 2017: -86.2%FY 2018: -276.9%FY 2019: -52.8%FY 2020: -26.2%FY 2021: -66.8%FY 2022: -94.2%FY 2023: -172.4%FY 2024: -245.9%FY 2025: -404.0%
FY 2016 5y median -172.4% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 FY 2025
Operating Income -5.3%
FY 2016: 20.8%FY 2017: -27.6%FY 2018: 20.2%FY 2019: 11.9%FY 2020: -32.2%FY 2021: -87.2%FY 2022: -30.4%FY 2023: 17.0%FY 2024: 1.2%FY 2025: -5.3%
FY 2016 FY 2025
EPS (diluted) 37.8%
FY 2016: 36.7%FY 2017: 0.0%FY 2018: 74.0%FY 2019: 66.8%FY 2020: 37.9%FY 2021: -39.9%FY 2022: 3.7%FY 2023: 44.2%FY 2024: 52.5%FY 2025: 37.8%
FY 2016 FY 2025
Free Cash Flow -1.1%
FY 2016: 30.5%FY 2017: -13.1%FY 2018: -6.5%FY 2019: 34.6%FY 2020: -61.8%FY 2021: -80.0%FY 2022: 21.7%FY 2023: -9.1%FY 2024: -19.5%FY 2025: -1.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.7×
FY 2016: 11.2×FY 2017: 5.7×FY 2018: 5.7×FY 2019: 4.6×FY 2020: 15.9×FY 2021: 9.2×FY 2022: 9.6×FY 2023: 2.1×FY 2024: 1.8×FY 2025: 0.7×
FY 2016 5y median 2.1× FY 2025
Quick Ratio 0.7×
FY 2016: 11.2×FY 2017: 5.7×FY 2018: 5.7×FY 2019: 4.6×FY 2020: 15.9×FY 2021: 9.2×FY 2022: 9.2×FY 2023: 2.1×FY 2024: 1.8×FY 2025: 0.7×
FY 2016 5y median 2.1× FY 2025
Debt / Equity -0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 3.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.1×FY 2025: -0.1×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 0.2×
FY 2016: 1.5×FY 2017: 1.1×FY 2018: -1.7×FY 2019: 0.8×FY 2020: 2.6×FY 2021: 0.9×FY 2022: 1.2×FY 2023: 0.5×FY 2024: 0.3×FY 2025: 0.2×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -346×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -115×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31